* Third quarter revenue decreased 10.2% year-over-year to $61.8 million * Third quarter operating income decreased 32.7% to $5.2 million, or 8.4% of sales
* Third quarter net income decreased 38.8% year-over-year to $4.3 million, or $0.26 per share * Full Year 2014 net income expected to be in the range of $16.5 million to $17.0 million, or $0.99 to $1.02 per share CARLSTADT, N.J. , Nov.
Medicine, Inc. (NASDAQ:FMI) today announced that members of the
company's management team will present at the following upcoming
Live, listen-only webcasts of the presentations may be accessed by
visiting the investors section of the company’s website at investors.foundationmedicine.com .
Ascent Solar Technologies, Inc. (“Ascent”) (NASDAQ:ASTI), a manufacturer
of state-of-the-art, flexible thin-film photovoltaic modules, integrated
into off-grid applications and the company’s EnerPlex™ series of
consumer products, announced today the Company’s third quarter results
ended September 30, 2014.
Sign-up for VirtualScopics, Inc. Reports Third Quarter And Nine Months 2014 Financial Results; Third Quarter Awards Outstanding And Bookings Up 29%, Quarterly Revenues Up 23% From The Prior Year investment picks
New study involving 10 canadian research sites shows high cure rates for genotype 1 hepatitis C using new Bristol-Myers Squibb all-oral daclatasvir TRIO fixed-dose combination Canada NewsWire
MONTREAL , Nov.
Sign-up for New study involving 10 canadian research sites shows high cure rates for genotype 1 hepatitis C using new Bristol-Myers Squibb all-oral daclatasvir TRIO fixed-dose combination investment picks
By Barbara Kollmeyer, MarketWatch Strategist says a short-term correction is coming
MADRID (MarketWatch) -- Stock futures tracked global markets higher on Thursday as investors readied for weekly jobless claims and earnings from retailers such as Wal-Mart Stores Inc., but strategists continued to voice concerns over a potential correction for stocks.
C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK:945 Substantive progress made on growth strategies in the third quarter of
Developing our Asian opportunity to the fullest - Achieved record insurance sales on a constant currency basis, with
double digit growth in Hong Kong , Indonesia and our Asia Other
businesses as well as continued success in Japan ; continued to build
momentum in wealth sales reflecting successful product launches and
marketing campaigns; delivered strong growth in core earnings, driven
by higher sales volumes and favourable policyholder experience.
3Q14 Revenues up 4.7% YoY to RMB409.1 Million 3Q14 Adjusted Net Income down 27.0% YoY to RMB22.7 Million 3Q14 Adjusted EBITDA down 13.4% YoY to RMB45.8 Million
Announces Departure of CFO CHONGQING, China , Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.